NYSE:PRGOPharmaceuticals
Should Perrigo’s (PRGO) Steep Goodwill Impairment and Wider Losses Prompt a Rethink From Investors?
Perrigo Company plc recently reported first-quarter 2026 results showing sales of US$969.2 million, a very large net loss of US$398.6 million, and goodwill impairment charges of US$330.8 million, compared with much smaller losses and impairments a year earlier.
Despite this sharp deterioration in reported earnings and higher impairment charges, Perrigo reaffirmed its 2026 guidance calling for total net sales to decline between 5.5% and 1.5%, underscoring continued operational...